Treatment of Liver Cancer

被引：290

作者：

Liu, Chun-Yu ^{[1
,2
,3
]}

Chen, Kuen-Feng ^{[4
,5
]}

Chen, Pei-Jer ^{[4
,5
,6
,7
]}

机构：

[1] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei 112, Taiwan

[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan

[3] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan

[4] Natl Taiwan Univ, Dept Med Res, Coll Med, Taipei 112, Taiwan

[5] Natl Taiwan Univ, Coll Med, Natl Ctr Excellence Clin Trial & Res, Taipei 112, Taiwan

[6] Natl Taiwan Univ Hosp, Grad Inst Mol Med, Taipei 112, Taiwan

[7] Natl Taiwan Univ, Coll Med, Taipei 112, Taiwan

来源：

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2015年 / 5卷 / 09期

关键词：

UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TARGETED ONCOLYTIC POXVIRUS; RANDOMIZED CONTROLLED-TRIAL; PORTAL-VEIN EMBOLIZATION; 7 STAGING SYSTEMS; LONG-TERM SURVIVAL; TRANSARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; ARTERIAL EMBOLIZATION; CURATIVE RESECTION;

D O I：

10.1101/cshperspect.a021535

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. A number of staging systems have been developed, reflecting the heterogeneity of primary liver cancer, regional preferences, and regional variations in resectability or transplant eligibility. Multimodality treatments are available for this heterogeneous malignancy, and there are variations in the management recommendations for liver cancers across specialties and geographic regions. Novel treatment strategies have merged with the advance of newtreatment modalities. This work focuses on reviewing the incidence, staging, and treatment of liver cancer.

引用

页数：16

共 140 条

[1] Portal vein embolization: rationale, technique and future prospects [J].